Cetuximab.

J Graham, M Muhsin… - Nature reviews Drug …, 2004 - search.ebscohost.com
J Graham, M Muhsin, P Kirkpatrick
Nature reviews Drug discovery, 2004search.ebscohost.com
Abstract Cetuximab (Erbitux; ImClone Systems/Bristol-Myers Squibb) is a monoclonal
antibody that binds to the epidermal growth factor receptor, which is important in the growth
of many cancers. In February 2004, it was granted accelerated approval by the FDA for the
treatment of metastatic colorectal cancer on the basis of tumour response rates in Phase II
trials.
Abstract Cetuximab (Erbitux; ImClone Systems/Bristol-Myers Squibb) is a monoclonal antibody that binds to the epidermal growth factor receptor, which is important in the growth of many cancers. In February 2004, it was granted accelerated approval by the FDA for the treatment of metastatic colorectal cancer on the basis of tumour response rates in Phase II trials.
search.ebscohost.com